Siga Technologies (SIGA) Shares Outstanding (2010 - 2025)
Siga Technologies' (SIGA) quarterly Shares Outstanding (Entity) came in at $71.6 million in Q4 2025, little changed YoY from $71.4 million in Q4 2024, and little changed on a QoQ basis from $71.6 million in Q3 2025.
Siga Technologies (SIGA) Shares Outstanding (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Shares Outstanding (Entity) data on file, last reported at $71.6 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) changed 0.29% year-over-year to $71.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $71.6 million (changed 0.29% YoY) and the FY2025 annual result came in at $71.6 million, changed 0.29% from the prior year.
- Shares Outstanding (Entity) steadied at $71.6 million in Q4 2025, from $71.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $76.2 million in Q1 2021 to a low of $71.1 million in Q2 2023.
- A 5-year average of $72.3 million and a median of $71.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) slipped 5.93% — and 2025, when it advanced 0.45%.
- Tracing SIGA's Shares Outstanding (Entity) over 5 years: stood at $73.5 million in 2021, then decreased by 1.18% to $72.7 million in 2022, then dropped by 2.18% to $71.1 million in 2023, then increased by 0.44% to $71.4 million in 2024, then increased by 0.29% to $71.6 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $71.6 million (Q4 2025), $71.6 million (Q3 2025), and $71.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | 71.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.60 Mn |
| Sep 30, 2025 | 71.60 Mn |
| Jun 30, 2025 | 71.47 Mn |
| Mar 31, 2025 | 71.43 Mn |
| Dec 31, 2024 | 71.25 Mn |
| Sep 30, 2024 | 71.37 Mn |
| Jun 30, 2024 | 71.15 Mn |
| Mar 31, 2024 | 71.09 Mn |
| Dec 31, 2023 | 71.36 Mn |
| Sep 30, 2023 | 71.08 Mn |
| Jun 30, 2023 | 71.09 Mn |
| Mar 31, 2023 | 72.20 Mn |
| Dec 31, 2022 | 72.93 Mn |
| Sep 30, 2022 | 73.02 Mn |
| Jun 30, 2022 | 72.68 Mn |
| Mar 31, 2022 | 73.07 Mn |
| Dec 31, 2021 | 75.32 Mn |
| Sep 30, 2021 | 74.84 Mn |
| Jun 30, 2021 | 75.81 Mn |
| Mar 31, 2021 | 76.76 Mn |